标题:JAK/STAT Signal Transduction: Promising Attractive Targets for Immune, Inflammatory and Hematopoietic Diseases
作者:Gao, Qianwen; Liang, Xuewu; Shaikh, Abdul Sami; Zang, Jie; Xu, Wenfang; Zhang, Yingjie
作者机构:[Gao, Qianwen; Liang, Xuewu; Zang, Jie; Xu, Wenfang; Zhang, Yingjie] Shandong Univ, Sch Pharmaceut Sci, Dept Med Chem, 44 West Wenhua Rd, Jinan 250012 更多
通讯作者:Xu, WF;Zhang, YJ
通讯作者地址:[Xu, WF; Zhang, YJ]Shandong Univ, Sch Pharmaceut Sci, Dept Med Chem, 44 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
来源:CURRENT DRUG TARGETS
出版年:2018
卷:19
期:5
页码:487-500
DOI:10.2174/1389450117666161207163054
关键词:Inflammation; JAK; STAT; kinase inhibitors; selectivity; signal; transduction
摘要:Background: JAK/STAT signal pathway, a requisite part in the signaling process of growth factors and cytokines, has become attractive targets for numerous immune, inflammatory and hematopoietic diseases.; Objective: Herein, we present a review of the JAK/STAT signal pathway, the structure, biological function, mechanism of the JAKs and STATs along with a summary of the up-to-date clinical or approved JAK inhibitors which are involved in the treatment of various kinds of tumors and other immunity indications. Moreover, kinds of recently discovered JAKs inhibitors with potent activity or promising selectivity are also briefly discussed.; Conclusion: Research and development of isoform selective JAK inhibitors has become a hot topic in this field. With the assistance of high throughput screening and rational drug design, more and more JAK inhibitors with improved selective profiles will be discovered as biological probes and even therapeutic agents.
收录类别:SCOPUS;SCIE
WOS核心被引频次:2
Scopus被引频次:1
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85046004146&doi=10.2174%2f1389450117666161207163054&partnerID=40&md5=1d552e3df07aa2d991ac2e51f76ee9ad
TOP